Streetbeat News

Products Services

PLUR

Pluri shares surged following the announcement of a new patent grant for a system and methods aimed at expanding and activating immune cells on a large scale. This development could potentially enhance the company's offerings in the biotechnology sector, signaling a positive outlook for its future operations and market position.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:51 am

OCGN

Ocugen's stock price increased following the announcement of the U.S. FDA's clearance for an IND amendment, allowing the company to initiate a Phase 3 clinical trial of OCU400.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:47 am

BRTX

BioRestorative Therapies, Inc. (BRTX) has partnered with Galen Patient Recruitment to expedite patient enrollment in its Phase 2 trial of BRTX-100 for chronic lumbar disc disease. This collaboration, along with an increase in trial capacity, aims to accelerate the study's completion.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:46 am

UCAR

U Power shares surged following the announcement of a formal commercial rollout of its battery-swapping and sharing model for two-wheeled and light four-wheeled electric vehicles in Wuhu, Anhui Province, China.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:41 am

TSLA

Tesla Inc. (TSLA) shares are rebounding in premarket trading after a 6% drop last week due to rumors of a scrapped low-cost EV project. Despite CEO Elon Musk's denial, the stock fell 3.63% on Friday. The rebound, with shares up 1.86% to $167.96, is attributed to Musk's announcement of a robotaxi unveiling on Aug. 8, which has analysts optimistic about Tesla's full-self driving software. Gene Munster of Deepwater Asset Management supports Tesla's focus on robotaxis, predicting their deployment by 2027. Technical factors and the stock's bounce off a support level also contribute to the positive outlook, with investors eyeing the upcoming Q1 earnings report on April 23rd.

Portfolio Pulse from Shanthi Rexaline

April 08, 2024 | 11:32 am

EQNR

EuroGreen Maritime SAS has entered a seven-year charter agreement with Equinor ASA for four advanced hybrid battery/dual-fuel methanol tankers with wingsails, marking a significant step towards sustainable maritime solutions.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:32 am

PTN

Palatin Technologies, Inc. (NYSE:PTN) announced the presentation of topline results from its Phase 3 PL9643 MELODY-1 clinical trial for dry eye disease at the ASCRS 2024. The trial evaluated the safety and efficacy of PL9643 versus vehicle.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:31 am

VERO

Venus Concept Inc. announced it has received Israeli regulatory approval for Venus Bliss MAX, a medical aesthetic technology. The product was first launched in the U.S. in Q1 2022 after FDA clearance and is available in approved jurisdictions internationally.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:31 am

GRTS

Gritstone Bio presented an update on its T cell epitope discovery platform, EDGE, at AACR 2024, highlighting significant improvements in predicting peptide presentation by HLA Class I, associated with CD8+ T cells, since its initial results in 2018.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:26 am

GILT

Gilat Satellite Networks Ltd. (GILT) has received over $3M in orders from a leading IFC Service Provider to expand its In-Flight Connectivity capabilities, primarily for Gilat's Taurus Aero modems.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:21 am